FR2803751B1 - Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe - Google Patents

Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe

Info

Publication number
FR2803751B1
FR2803751B1 FR0000551A FR0000551A FR2803751B1 FR 2803751 B1 FR2803751 B1 FR 2803751B1 FR 0000551 A FR0000551 A FR 0000551A FR 0000551 A FR0000551 A FR 0000551A FR 2803751 B1 FR2803751 B1 FR 2803751B1
Authority
FR
France
Prior art keywords
dehydroepiandrosterone
precursors
derivatives
oral use
direct acting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0000551A
Other languages
English (en)
Other versions
FR2803751A1 (fr
Inventor
La Charriere Olivier De
Stephanie Nouveau
Francoise Forette
Etienne Emile Baulieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to FR0000551A priority Critical patent/FR2803751B1/fr
Priority to US10/181,002 priority patent/US20030050293A1/en
Priority to PCT/FR2001/000138 priority patent/WO2001052856A2/fr
Priority to EP01907605A priority patent/EP1248627A2/fr
Priority to AU2001235528A priority patent/AU2001235528A1/en
Priority to JP2001552903A priority patent/JP2003520238A/ja
Publication of FR2803751A1 publication Critical patent/FR2803751A1/fr
Application granted granted Critical
Publication of FR2803751B1 publication Critical patent/FR2803751B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
FR0000551A 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe Expired - Fee Related FR2803751B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0000551A FR2803751B1 (fr) 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe
US10/181,002 US20030050293A1 (en) 2000-01-17 2001-01-17 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
PCT/FR2001/000138 WO2001052856A2 (fr) 2000-01-17 2001-01-17 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives comme agents hydratants a action directe
EP01907605A EP1248627A2 (fr) 2000-01-17 2001-01-17 Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives comme agents hydratants a action directe
AU2001235528A AU2001235528A1 (en) 2000-01-17 2001-01-17 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
JP2001552903A JP2003520238A (ja) 2000-01-17 2001-01-17 直接作用を有する水和剤としての、経口投与による、デヒドロエピアンドロステロン、その前駆体および誘導体の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000551A FR2803751B1 (fr) 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe

Publications (2)

Publication Number Publication Date
FR2803751A1 FR2803751A1 (fr) 2001-07-20
FR2803751B1 true FR2803751B1 (fr) 2004-03-12

Family

ID=8845991

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0000551A Expired - Fee Related FR2803751B1 (fr) 2000-01-17 2000-01-17 Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe

Country Status (6)

Country Link
US (1) US20030050293A1 (fr)
EP (1) EP1248627A2 (fr)
JP (1) JP2003520238A (fr)
AU (1) AU2001235528A1 (fr)
FR (1) FR2803751B1 (fr)
WO (1) WO2001052856A2 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326901A (en) * 1965-04-16 1967-06-20 Irwin I Lubowe Pregnenolone salts of allantoin
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
US4542129A (en) * 1982-08-16 1985-09-17 Norman Orentreich DHEA Formulations and methods for treating dry skin
EP0319638A1 (fr) * 1987-12-08 1989-06-14 Estee Lauder Inc. Compositions cosmétiques et pharmaceutiques contenant des liposomes et procédés pour l'utilisation de telles compositions
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
JPH07196467A (ja) * 1993-12-28 1995-08-01 Kanebo Ltd 表皮角質化促進剤
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
EP0908183A1 (fr) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Déhydroépiandrostérone ou ses dérivés pour augmenter la quantité d'acide hyaluronique dans la peau
FR2803519B1 (fr) * 2000-01-12 2002-03-22 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau

Also Published As

Publication number Publication date
US20030050293A1 (en) 2003-03-13
WO2001052856A2 (fr) 2001-07-26
AU2001235528A1 (en) 2001-07-31
WO2001052856A3 (fr) 2002-06-06
JP2003520238A (ja) 2003-07-02
FR2803751A1 (fr) 2001-07-20
EP1248627A2 (fr) 2002-10-16

Similar Documents

Publication Publication Date Title
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
MA26932A1 (fr) Derives d'imidazole.
ATE342708T1 (de) Kosmetiktuch
DK1051179T3 (da) Anti-estrogen- plus progestin-holdige orale kontraceptiva
FR2831441B1 (fr) Utilisation cosmetique de derives de la dhea
ATE455754T1 (de) Arylsulfonamid-substituierte hydroxamsäure- derivate
RS50089B (sr) Suspenzija ziprasidona
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
NO20021452D0 (no) Orale kontrollerte frigivelsesformuleringer
FR2803751B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe
NO20021965L (no) Hydroksamsyrederivat som inhibitor av dannelse av opplöselig, human CD23
FR2803519B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau
FR2803750B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
FR2803518B1 (fr) Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives metaboliques comme regulateurs de la pigmentation
UA3956S (uk) Півпальто жіноче хутрове
UA4040S (uk) Півпальто жіноче хутрове
UA3910S (uk) Півпальто жіноче хутрове
UA3914S (uk) Півпальто жіноче хутрове
UA3923S (uk) Півпальто жіноче хутрове
UA3947S (uk) Півпальто жіноче хутрове
UA3948S (uk) Півпальто жіноче хутрове
UA3949S (uk) Півпальто жіноче хутрове
UA3950S (uk) Півпальто жіноче хутрове
UA3955S (uk) Півпальто жіноче хутрове
UA4023S (uk) Півпальто жіноче хутрове

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130930